Inovio Pharmaceuticals, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $355.1M | $59.0M |
| Jun 2022 | — | $297.7M | $41.1M |
| Sep 2022 | — | $266.7M | $22.0M |
| Dec 2022 | — | $222.4M | $46.3M |
| Mar 2023 | — | $199.2M | $28.2M |
| Jun 2023 | — | $169.4M | $52.7M |
| Sep 2023 | — | $138.2M | $18.8M |
| Dec 2023 | — | $117.3M | $14.3M |
| Mar 2024 | — | $94.4M | $19.6M |
| Jun 2024 | — | $96.7M | $34.4M |
| Sep 2024 | — | $73.5M | $21.7M |
| Dec 2024 | — | $68.5M | $65.8M |
| Mar 2025 | — | $51.3M | $39.9M |
| Jun 2025 | — | $28.5M | $24.4M |
| Sep 2025 | — | $-7.7M | $36.6M |
| Dec 2025 | — | $24.1M | $44.3M |
| Mar 2026 | — | $6.1M | $26.3M |
| Jun 2026 | — | $4.4M | $31.5M |